R. T. Chlebowski

1.3k total citations
21 papers, 915 citations indexed

About

R. T. Chlebowski is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, R. T. Chlebowski has authored 21 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 6 papers in Cancer Research and 5 papers in Genetics. Recurrent topics in R. T. Chlebowski's work include Cancer Risks and Factors (7 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (4 papers). R. T. Chlebowski is often cited by papers focused on Cancer Risks and Factors (7 papers), Breast Cancer Treatment Studies (6 papers) and Estrogen and related hormone effects (4 papers). R. T. Chlebowski collaborates with scholars based in United States, United Kingdom and Italy. R. T. Chlebowski's co-authors include Linda Lillington, Aman U. Buzdar, Paul P. Carbone, Matthew L. Baum, I. Craig Henderson, O Abe, Martin D. Abeloff, Kasper Langebjerg Andersen, J. Carpenter and Rory Collins and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

R. T. Chlebowski

20 papers receiving 865 citations

Peers

Countries citing papers authored by R. T. Chlebowski

Since Specialization

Citations

This map shows the geographic impact of R. T. Chlebowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. T. Chlebowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. T. Chlebowski more than expected).

Fields of papers citing papers by R. T. Chlebowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. T. Chlebowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. T. Chlebowski. The network helps show where R. T. Chlebowski may publish in the future.

Co-authorship network of co-authors of R. T. Chlebowski

This figure shows the co-authorship network connecting the top 25 collaborators of R. T. Chlebowski. A scholar is included among the top collaborators of R. T. Chlebowski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. T. Chlebowski. R. T. Chlebowski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract GS5-07: Weight change in postmenopausal women and breast cancer risk in the women's health initiative observational study 2018 ·Cancer Research ·R. T. Chlebowski, Juhua Luo, (unknown), Michael S. Simon, William Barrington, Kerryn W. Reding, JE Manson, Tomáš Rohan, (unknown), Dorothy S. Lane, Howard D. Strickler, Yasmin Mossavar‐Rahmani, Jo L. Freudenheim, (unknown), Marcia L. Stefanick	3
2	Abstract S5-04: Low-fat dietary pattern and breast cancer overall survival in the women's health initiative dietary modification randomized controlled trial 2017 ·Cancer Research ·R. T. Chlebowski, (unknown), (unknown), Garnet L. Anderson, JE Manson, (unknown), (unknown), (unknown), Dorothy S. Lane, (unknown), Mara Z. Vitolins, Catherine Womack, Ling Qi, Lifang Hou, Fridtjof Thomas, (unknown)	2
3	Multivitamin and mineral use and breast cancer mortality in older women with invasive breast cancer in the women’s health initiative 2013 ·Breast Cancer Research and Treatment ·Sylvia Wassertheil‐Smoller, Aileen P. McGinn, Nicole M. Budrys, R. T. Chlebowski, Gloria Ho, Karen Johnson, Dorothy S. Lane, Wenjun Li, Marian L. Neuhouser, Juliann Saquib, James M. Shikany, Yiqing Song, Cynthia A. Thomson	11
4	Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3—A randomized, placebo-controlled clinical trial. 2011 ·Journal of Clinical Oncology ·(unknown), (unknown), (unknown), (unknown), R. T. Chlebowski, Jean Wactawski‐Wende, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2
5	P4-11-13: Influence of Two Years of Exemestane on Bone Mineral Density in Postmenopausal Women at Increased Risk of Developing Breast Cancer; a Companion Study to the NCIC CTG MAP.3 Trial. 2011 ·Cancer Research ·(unknown), Harriet Richardson, JN Ingle, R. T. Chlebowski, (unknown), J. E. Garber, (unknown), Andrea Hiltz, (unknown), (unknown)	1
6	P3-11-02: Changing Paradigms for Breast Cancer Chemoprevention? 2011 ·Cancer Research ·R. T. Chlebowski	0
7	A 24-month subgroup analysis of the effect of denosumab on bone mineral density in women with breast cancer undergoing aromatase inhibitor therapy. 2009 ·Cancer Research ·(unknown), (unknown), R. T. Chlebowski, Devchand Paul, Silvana Spadafora, (unknown), (unknown)	2
8	An assessment of breast cancer survivorship awareness and educational needs among health care professionals 2009 ·Journal of Clinical Oncology ·(unknown), R. T. Chlebowski	3
9	0133 A survey of oncologists on the duration of adjuvant aromatase inhibitor therapy - factors that influence treatment decisions in early breast cancer 2009 ·The Breast ·(unknown), Dereck D. Amakye, R. T. Chlebowski	1
10	Conjugated Equine Estrogen and Risk of Benign Proliferative Breast Disease: A Randomized Controlled Trial 2008 ·JNCI Journal of the National Cancer Institute ·Thomas E. Rohan, Abdissa Negassa, R. T. Chlebowski, Laurel A. Habel, Anne McTiernan, Mindy Ginsberg, Sylvia Wassertheil‐Smoller, David L. Page	35
11	FOUR AUTHORS REPLY 2008 ·American Journal of Epidemiology ·Ross L. Prentice, R. T. Chlebowski, Jacques E. Rossouw, Garnet L. Anderson	3
12	Frequency and Predictive Value of a Mammographic Recommendation for Short-Interval Follow-Up 2003 ·JNCI Journal of the National Cancer Institute ·S. Yasmeen, Patrick S. Romano, Mary Pettinger, R. T. Chlebowski, John A. Robbins, Dorothy S. Lane, Susan L. Hendrix	65
13	Evaluation of a smoking cessation program for pregnant minority women. 1995 ·PubMed ·Linda Lillington, Jacqueline Royce, D. Novak, (unknown), R. T. Chlebowski	52
14	A decade of breast cancer clinical investigation: results as reported in the Program/Proceedings of the American Society of Clinical Oncology. 1994 ·Journal of Clinical Oncology ·R. T. Chlebowski, Linda Lillington	25
15	Long-term effects of early nutritional support with new enterotropic peptide-based formula vs. standard enteral formula in HIV-infected patients: randomized prospective trial. 1994 ·PubMed ·R. T. Chlebowski, Gildon Beall, Mary B. Grosvenor, Linda Lillington, (unknown), (unknown), (unknown), (unknown), Mark McCamish, (unknown)	53
16	Late mortality and levamisole adjuvant therapy in colorectal cancer 1994 ·British Journal of Cancer ·R. T. Chlebowski, Linda Lillington, (unknown), (unknown)	15
17	Adherence to an enteral supplement program in patients with HIV infection 1992 ·Clinical Nutrition ·R. T. Chlebowski, Viva Tai, (unknown), Frederick O. Cope, (unknown), (unknown), Gildon Beall	4
18	Combination versus sequential single agent chemotherapy in advanced breast cancer: associations with metastatic sites and long-term survival 1989 ·British Journal of Cancer ·R. T. Chlebowski, (unknown), John M. Weiner, (unknown), AA Bartolucci, (unknown)	32
19	Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210. 1987 ·Journal of Pharmacology and Experimental Therapeutics ·Steven A. Akman, James H. Doroshow, (unknown), R. T. Chlebowski, (unknown)	31
20	Adriamycin given as a weekly schedule without a loading course: clinically effective with reduced incidence of cardiotoxicity. 1980 ·PubMed ·R. T. Chlebowski, (unknown), Reginald P. Pugh, (unknown), Edwin M. Jacobs, T F Pajak, Joseph R. Bateman	94

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact